Virus News and Research

Latest Virus News and Research

IAS announces recipients of CNIHR grants

IAS announces recipients of CNIHR grants

U.N. report released ahead of International AIDS Conference: HIV prevalence drops among young Africans

U.N. report released ahead of International AIDS Conference: HIV prevalence drops among young Africans

Administration to unveil first national HIV/AIDS strategy today

Administration to unveil first national HIV/AIDS strategy today

Opinions: Haitian rebuilding; Nuclear state vaccine initiatives; HIV rights abuses in China; HIV vaccine

Opinions: Haitian rebuilding; Nuclear state vaccine initiatives; HIV rights abuses in China; HIV vaccine

Today's OpEds: The Berwick backlash; HIV screening a part of routine care; And why Congress should provide Medicaid help to states

Today's OpEds: The Berwick backlash; HIV screening a part of routine care; And why Congress should provide Medicaid help to states

First Edition: July 13, 2010

First Edition: July 13, 2010

ABL signs international distribution agreement for Virco BVBA's HIV resistance interpretation system

ABL signs international distribution agreement for Virco BVBA's HIV resistance interpretation system

Researchers watch armed tumor-seeking immune system cells attack dangerous melanomas in real time

Researchers watch armed tumor-seeking immune system cells attack dangerous melanomas in real time

Inadequate funding for research, prevention will not help eradicate HIV in Quebec

Inadequate funding for research, prevention will not help eradicate HIV in Quebec

Sewage that overflows into urban creeks, streams can promote spread of West Nile virus: Study

Sewage that overflows into urban creeks, streams can promote spread of West Nile virus: Study

Biomagnetics signs LOI to acquire Lanzhou Sanhuan New Technology Development

Biomagnetics signs LOI to acquire Lanzhou Sanhuan New Technology Development

Report on program to develop, test nasally delivered H5N1 vaccine filed with Japan's MHLW

Report on program to develop, test nasally delivered H5N1 vaccine filed with Japan's MHLW

Medivir reports 24-week interim Phase 2b results of TMC435 in treatment-naïve patients with HCV genotype-1

Medivir reports 24-week interim Phase 2b results of TMC435 in treatment-naïve patients with HCV genotype-1

Lectures on DermaVir to be presented at International Conference on Nanosciences & Nanotechnologies

Lectures on DermaVir to be presented at International Conference on Nanosciences & Nanotechnologies

Midatech, Immunotope form joint venture to develop antigen based products for immune therapies

Midatech, Immunotope form joint venture to develop antigen based products for immune therapies

Discovery of antibodies that kill more than 90% of HIV viruses gives new hope for vaccine

Discovery of antibodies that kill more than 90% of HIV viruses gives new hope for vaccine

Science special section examines HIV/AIDS in Russia, Ukraine

Science special section examines HIV/AIDS in Russia, Ukraine

UM researcher uses computer algorithms to develop vaccines for new strains of influenza viruses

UM researcher uses computer algorithms to develop vaccines for new strains of influenza viruses

HHS to give states $25 million for HIV drugs; Researchers identify antibodies that may help in AIDS vaccine research

HHS to give states $25 million for HIV drugs; Researchers identify antibodies that may help in AIDS vaccine research

Media outlets examine efforts to tackle HIV/AIDS worldwide

Media outlets examine efforts to tackle HIV/AIDS worldwide

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.